Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases

被引：0
|
作者：
Elberdin, Laida [1 ]
Outeda, Maria [1 ]
Mateos, Maria [1 ]
Martinez, Cristina [1 ]
Salvador, Pilar [1 ]
Angeles Porta, Maria [1 ]
Isabel Martin, Maria [1 ]
机构：
[1] A Coruna Univ Hosp Complex, Integrated Adm Management, Dept Pharm, La Coruna, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2017年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
TDMP011
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [41] Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy
    Bar-Yoseph, H.
    Levhar, N.
    Selinger, L.
    Manor, U.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Eliakim, R.
    Ben-Horin, S.
    Chowers, Y.
    Ungar, B.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) : 212 - 218
  • [42] RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Facchin, S.
    Buda, A.
    Cardin, R.
    Agbariah, N.
    Zingone, F.
    De Boni, M.
    D'Inca, R.
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 : E110 - E111
  • [43] Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
    Semmler, J. M.
    Pilch, A.
    Armbruster, F. P.
    Dignass, A.
    Kruis, W.
    Stein, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S41 - S41
  • [44] Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapy
    Del Nero, L.
    Bodini, G.
    Giannini, E.
    Anjali, J.
    Savarino, V.
    Savarino, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S270 - S271
  • [45] The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD
    Ungar, B.
    Anafy, A.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Ron, Y.
    Yanai, H.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S113 - S113
  • [46] IDENTIFICATION OF A CUT-OFF FOR PERSISTENT ANTI-INFLIXIMAB ANTIBODIES AS A PREDICTOR OF RESPONSE TO INFLIXIMAB MONOTHERAPY
    Del Nero, L.
    Bodini, G.
    Giannini, E. G.
    Savarino, V
    De Maria, C.
    Baldissarro, I
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E77 - E77
  • [47] Anti-infliximab antibodies are eliminated more rapidly in vivo than non-immune antibodies in the presence of infliximab
    Rojas, J
    Rutkoski, T
    Vennarini, J
    Jang, H
    Wagner, CL
    [J]. FASEB JOURNAL, 2003, 17 (07): : C138 - C138
  • [48] Clinical relevance and inter-test reliability of anti-infliximab antibodies and infliximab trough levels in patients with inflammatory bowel disease
    Guiotto, Cristina
    Daperno, Marco
    Frigeri, Francesco
    Vizzini, Margherita
    Cerruti, Roberta
    Ercole, Elena
    Cosimato, Maurizio
    Lavagna, Alessandro
    Germano, Laura
    Migliardi, Marco
    Rocca, Rodolfo
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (02) : 138 - 143
  • [49] Anti-infliximab antibodies: How to compare old and new data?
    Imbrechts, Maya
    Van Stappen, Thomas
    Compernolle, Griet
    Tops, Sophie
    Gils, Ann
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 177
  • [50] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD - authors' reply
    Ben-Horin, S.
    Chowers, Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 501 - 501
12345